novelcov2019cure
Moderna Sees 20 Million Doses of COVID-19 Vaccine Candidate by Year-End
Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year while maintaining its goal of readying 500 million to 1 billion doses in 2021. The company is working with Switzerland’s Lonza Group AG and Spain’s Laboratorios Farmacéuticos Rovi to make the vaccine outside the United States. Check the latest update on the Covid-19 vaccine.
Moderna Sees 20 Million Doses of COVID-19 Vaccine Candidate by Year-End
Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year while maintaining its goal of readying 500 million to 1 billion doses in 2021. The company is working with Switzerland’s Lonza Group AG and Spain’s Laboratorios Farmacéuticos Rovi to make the vaccine outside the United States. Check the latest update on the Covid-19 vaccine.